Conatus Pharmaceuticals Inc. (CNAT): Price and Financial Metrics
CNAT Price/Volume Stats
Current price | $0.56 | 52-week high | $1.07 |
Prev. close | $0.56 | 52-week low | $0.23 |
Day low | $0.54 | Volume | 1,696,900 |
Day high | $0.59 | Avg. volume | 1,283,592 |
50-day MA | $0.38 | Dividend yield | N/A |
200-day MA | $0.37 | Market Cap | 18.44M |
CNAT Stock Price Chart Interactive Chart >
Conatus Pharmaceuticals Inc. (CNAT) Company Bio
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. The company was founded in 2005 and is based in San Diego, California.
Latest CNAT News From Around the Web
Below are the latest news stories about Conatus Pharmaceuticals Inc that investors may wish to consider to help them evaluate CNAT as an investment opportunity.
Intercept (ICPT) Gains 7.5% YTD on Progress in NASH SpaceIntercept (ICPT) stock gains as it becomes the forerunner in the NASH drug race. |
NASH Scorecard Year to Date: The Winners and the LosersNASH sees a highly rewarding market with candidates of blockbuster potential. Let us take a look at the hits and misses in this space so far this year. |
Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board MemberSAN DIEGO, Nov. 18, 2019 -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional. |
Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue EstimatesConatus (CNAT) delivered earnings and revenue surprises of 16.67% and -48.06%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock? |
Conatus Pharmaceuticals Reports Third Quarter 2019 Financial ResultsSAN DIEGO, Nov. 05, 2019 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced financial results for the quarter and nine months ended September 30, 2019. Recent. |
CNAT Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | -48.15% |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | 0.00% |
2019 | -76.88% |
Continue Researching CNAT
Want to do more research on Conatus Pharmaceuticals Inc's stock and its price? Try the links below:Conatus Pharmaceuticals Inc (CNAT) Stock Price | Nasdaq
Conatus Pharmaceuticals Inc (CNAT) Stock Quote, History and News - Yahoo Finance
Conatus Pharmaceuticals Inc (CNAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...